American Century Companies’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.4M | Buy |
1,501,420
+212,633
| +16% | +$6.72M | 0.03% | 699 |
|
|
2025
Q1 | $42.8M | Buy |
1,288,787
+186,183
| +17% | +$6.18M | 0.03% | 689 |
|
|
2024
Q4 | $37.9M | Buy |
1,102,604
+246,140
| +29% | +$8.47M | 0.02% | 745 |
|
|
2024
Q3 | $34.3M | Buy |
856,464
+174,928
| +26% | +$7M | 0.02% | 779 |
|
|
2024
Q2 | $20.6M | Buy |
681,536
+238,140
| +54% | +$7.18M | 0.01% | 949 |
|
|
2024
Q1 | $14.9M | Buy |
443,396
+236,977
| +115% | +$7.96M | 0.01% | 1042 |
|
|
2023
Q4 | $6.67M | Buy |
206,419
+810
| +0.4% | +$26.2K | ﹤0.01% | 1303 |
|
|
2023
Q3 | $6.74M | Sell |
205,609
-267,431
| -57% | -$8.76M | 0.01% | 1223 |
|
|
2023
Q2 | $16.6M | Sell |
473,040
-141,801
| -23% | -$4.99M | 0.01% | 842 |
|
|
2023
Q1 | $20.1M | Sell |
614,841
-38,441
| -6% | -$1.25M | 0.02% | 748 |
|
|
2022
Q4 | $36M | Sell |
653,282
-60,583
| -8% | -$3.34M | 0.03% | 517 |
|
|
2022
Q3 | $31.6M | Buy |
713,865
+57,919
| +9% | +$2.57M | 0.03% | 512 |
|
|
2022
Q2 | $32M | Buy |
655,946
+89,638
| +16% | +$4.37M | 0.03% | 528 |
|
|
2022
Q1 | $27.6M | Buy |
566,308
+90,484
| +19% | +$4.4M | 0.02% | 612 |
|
|
2021
Q4 | $20.3M | Buy |
475,824
+287,013
| +152% | +$12.2M | 0.01% | 699 |
|
|
2021
Q3 | $7.24M | Buy |
188,811
+70
| +0% | +$2.68K | 0.01% | 926 |
|
|
2021
Q2 | $5.33M | Buy |
188,741
+37,650
| +25% | +$1.06M | ﹤0.01% | 975 |
|
|
2021
Q1 | $4.99M | Buy |
151,091
+32,542
| +27% | +$1.08M | ﹤0.01% | 940 |
|
|
2020
Q4 | $4.29M | Buy |
118,549
+17,337
| +17% | +$627K | ﹤0.01% | 909 |
|
|
2020
Q3 | $3.43M | Buy |
+101,212
| New | +$3.43M | ﹤0.01% | 855 |
|